CLVS - Clovis Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue55,51178-
Cost of Revenue11,73770-
Gross Profit43,7748-
Operating Expenses
Research Development142,498251,129269,251
Selling General and Administrative138,90715,7955,913
Non Recurring-105,817101,557
Total Operating Expenses---
Operating Income or Loss-237,631-372,733-376,721
Income from Continuing Operations
Total Other Income/Expenses Net-101,916533,156
Earnings Before Interest and Taxes-339,547-372,680-373,565
Interest Expense10,4288,4918,372
Income Before Tax-349,975-381,171-381,937
Income Tax Expense-3,578-32,034-29,076
Minority Interest---
Net Income From Continuing Ops-346,397-349,137-352,861
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-346,397-349,137-352,861
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-346,397-349,137-352,861